연구동향 분석

Risk Factor Associated with Recurrence after OM-89 (Uro-Vaxom®) Treatment for Female Recurrent Cystitis

Ji-Yeon Han 2019년

논문상세정보
인용/피인용
' Risk Factor Associated with Recurrence after OM-89 (Uro-Vaxom®) Treatment for Female Recurrent Cystitis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Diabetes mellitus
  • Immunotherapy
  • cystitis
  • recur-rence
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
895 0

0.0%

' Risk Factor Associated with Recurrence after OM-89 (Uro-Vaxom®) Treatment for Female Recurrent Cystitis' 의 참고문헌

  • 재발성 단순방광염 환자에서 유로박솜의 치료 효과 및 안전성: 다기관 공개 임상연구
    이승주 [2007]
  • Risk factors for recurrent urinary tract infection in young women
    Scholes D [2000]
  • Recurring urinary tract infection : incidence and risk factors
    Foxman B [1990]
  • Nonantibiotic prophylaxis for recurrent urinary tract infections : a systematic review and meta-analysis of randomized controlled trials
  • Natural history of recurrent urinary tract infections in women
    Stamm WE [1991]
  • Impaired leucocyte functions in diabetic patients
    Delamaire M [1997]
  • Immunoactive prophylaxis of recurrent urinary tract infections : a metaanalysis
    Naber KG [2009]
  • Epidemiology of urinary tract infections: incidence, morbidity, and economic costs
    Foxman B [2002]
  • Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli : studies with urine from diabetic and non-diabetic individuals
  • Antibiotics for preventing recurrent urinary tract infection in non-pregnant women
    Albert X [2004]
  • An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells
  • Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells : more in diabetic women than in control subjects